StockData
Insight Molecular Diagnostics Inc. logo

Insight Molecular Diagnostics Inc. (IMDX) stock

IMDXNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 7/30
$1.78−0.08 (-4.30%)

Close on Nov 17, 2026Market cap $58.25MP/E –Yield –

Insight Molecular Diagnostics enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Insight Molecular Diagnostics's enterprise value was $60.21M on Nov 11, 2026, against $157.07M a year earlier. Over the last 5 years it ranged from $1.46M to $196.00M, with a median of $41.75M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$60.21M-69.3%
2025Dec 31, 2025$196.00M+588.5%
2024Dec 31, 2024$28.47M+314.4%
2023Dec 29, 2023$6.87M+14.3%
2022Dec 30, 2022$6.01M-96.2%
2021Dec 31, 2021$156.64M+4.1%
2020Dec 31, 2020$150.44M+54.3%
2019Dec 31, 2019$97.50M+115.2%
2018Dec 31, 2018$45.30M-66.5%
2017Dec 29, 2017$135.07M-28.7%
2016Dec 30, 2016$189.50M+67.0%
2015Dec 31, 2015$113.49M–

More Insight Molecular Diagnostics figures

See a number that looks wrong?